SUBSCRIBE
SUBSCRIBE

Postmarket research

Drug Development
Blood Pressure Drug Shows Promise for Marfan Syndrome in Johns Hopkins University Study
June 26, 2008
 · 
1 min read
Drug Development
Painkillers Don’t Protect Against Melanoma, Kaiser Permanente Northern California Research Finds
June 25, 2008
 · 
1 min read
Drug Development
Kidney Transplant Patients May Benefit From Going Off of Certain Immunosuppressive Drugs, RTI Health Solutions Study Finds
June 24, 2008
 · 
1 min read
Drug Development
Potential Key to Better Drugs to Fight Toxoplasmosis Parasite Discovered in Indiana University School of Medicine Study
June 24, 2008
 · 
1 min read
Drug Development
Drug Reverses Mental Retardation Caused by Genetic Disorder in University of California, Los Angeles (UCLA) Study; Hope For Correcting How Autism Disrupts Brain
June 23, 2008
 · 
1 min read
Drug Development
Medication Improves Alcoholics’ Quality Of Life, University of Virginia Study Finds
June 23, 2008
 · 
1 min read
Drug Development
FDA to Drugmakers: Prepare for a Smackdown
June 23, 2008
 · 
1 min read
Drug Development
FDA Panel Backs Amgen Skin Drug for Use in Kids
June 19, 2008
 · 
1 min read
Drug Development
Diabetes Drug Slows Early-onset Puberty In Girls, University of Barcelona Study Shows
June 18, 2008
 · 
1 min read
Drug Development
Statins May Cut C-Section Risk, Say University of Liverpool Researchers
June 18, 2008
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Kowa Pharmaceuticals America Release: New Data Showed LIVALO® (pitavastatin) 4 mg had Neutral Effects on Fasting Serum Glucose and HbA1c Levels in HIV-infected Adults with Dyslipidemia
June 17, 2013
 · 
10 min read
Drug Development
Celgene International Sárl Oral Anti-Cancer Therapy REVLIMID® (lenalidomide) Now Indicated as a Treatment for Patients With Rare Form of Blood Disease
June 17, 2013
 · 
1 min read
Drug Development
Boehringer Ingelheim Corporation Release: New Long-Term Data Reinforce Safety Profile of Pradaxa® for Stroke Prevention in AF
June 17, 2013
 · 
1 min read
Drug Development
Novo Nordisk A/S Release: Victoza® (Liraglutide [rDNA Origin] Injection) Safety Profile Further Supported at Scientific Workshop on Pancreatitis, Diabetes and Pancreatic Cancer
June 14, 2013
 · 
5 min read
Drug Development
AbbVie Presents First Study Assessing the Role of Predefined Doses of Methotrexate When Used in Combination With HUMIRA™ (adalimumab) for Rheumatoid Arthritis
June 13, 2013
 · 
7 min read
Drug Development
Gilead Sciences, Inc.'s Viread Reduces HIV Risk for Drug Users in Study
June 13, 2013
 · 
1 min read
Drug Development
Genmab A/S Release: Teprotumumab Restarts Clinical Development in New Indication
June 12, 2013
 · 
1 min read
Drug Development
Merck & Co., Inc. Joins Novo Nordisk A/S to Reassure Safety of Diabetes Drugs
June 12, 2013
 · 
1 min read
Drug Development
Bristol-Myers Squibb Company’s Orencia Matches Abbott Laboratories’ Humira in Arthritis Study
June 12, 2013
 · 
8 min read
Drug Development
OXiGENE Announces Publication of Final FACT Study Data in Journal Thyroid Suggest Survival Benefit of ZYBRESTAT® in Patients With Anaplastic Thyroid Cancer
June 10, 2013
 · 
1 min read
Drug Development
Sanofi (France) Steps Up Diabetes Drive as Rivals Raise the Stakes
June 7, 2013
 · 
1 min read
Drug Development
Alexion Pharmaceuticals Inc. Release: Soliris® Significantly Improved Clinical Outcomes in Patients With aHUS in Pivotal Trials Published in New England Journal of Medicine
June 6, 2013
 · 
1 min read
Drug Development
Rebellious FDA Reviewer Insists ARB Heart Drugs Have Cancer Risk
May 31, 2013
 · 
1 min read
Drug Development
Prometheus Laboratories Inc. Launches PROCLIVITY 02, a Phase IV Multi-Center Study Comparing the Sequence of Proleukin® (Aldesleukin for Injection) and Yervoy® (Ipilimumab) in Patients With Metastatic Melanoma
May 30, 2013
 · 
9 min read
Drug Development
New Bird Flu Found to be Resistant to Roche’s Tamiflu
May 29, 2013
 · 
1 min read
Drug Development
Boehringer Ingelheim Corporation Release: New European Survey Highlights Ischaemic Stroke Protection as Treatment Priority for Patients With Atrial Fibrillation
May 28, 2013
 · 
1 min read
Drug Development
Positive Trial Results for Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S’s Abilify Maintena in Schizophrenia
May 22, 2013
 · 
17 min read
Drug Development
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S: Study Shows Effects of Treatment With ABILIFY MAINTENA#0153; (Aripiprazole) on Psychiatric Hospitalization Rates for Patients With Schizophrenia1
May 21, 2013
 · 
1 min read
Drug Development
Sunovion Pharmaceuticals Inc. Presents Data Showing 12 Months of Latuda® (lurasidone HCl) Treatment Resulted in Higher Remission Rates in Adult Patients With Schizophrenia Compared to Seroquel XR® (quetiapine XR)
May 21, 2013
 · 
1 min read
Drug Development
Sunovion Pharmaceuticals Inc. Presents Results From a One-year, Large Simple Safety Study of BROVANA® (arformoterol tartrate) Inhalation Solution
May 20, 2013
 · 
1 min read
Load More